Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases
نویسندگان
چکیده
منابع مشابه
Airway Microbiota and Allergic Diseases: Clinical Implications
Bronchial Asthma is an airway disease with variable degrees of bronchial mucosal inflammation and intermittent episodes of airway obstruction and bronchial hyperesponsivness. That asthma is a syndrome consisting of different phenotypes has been recognized for a long time by clinicians [1]. New evidence indicates that the composition of airway microbiota differs in states of health and disease. ...
متن کاملEDITORIAL: INFLAMMATORY AIRWAY DISEASES AND CLINICAL ALLERGY ASSEMBLY Inflammatory airway diseases and clinical allergy
A ssembly 5 of the European Respiratory Society (ERS) is the Inflammatory Airway Diseases and Clinical Allergy Assembly and consists of three Scientific Groups: 1) Airway Pharmacology and Treatment; 2) Monitoring Airway Diseases; and 3) Allergy and Immunology. The original focus of the Assembly was mostly on asthma, but in recent years, it has increasingly begun to encompass chronic obstructive...
متن کاملAllergy: Airway Epithelial Rac1 Suppresses Allergic Inflammation
Loss of Rac1 in airway epithelial cells has demonstrated its participation in the ingestion of apoptotic cells and, more importantly, has revealed an unexpected role for Rac1 in maintaining the anti-inflammatory and non-immunogenic environment of the lung and reducing the intensity of allergic sensitization.
متن کاملMast cells in allergic and inflammatory diseases.
Mast cells are important in the development of allergic and anaphylactic reactions, but also in acquired and innate immunity. There is also increasing evidence that mast cells participate in inflammatory diseases, where they can be activated by non-allergic triggers, such as neuropeptides and cytokines, often having synergistic effects as in the case of substance P (SP) and IL-33. Secretion of ...
متن کاملGene therapy for allergic airway diseases.
Airway diseases such as allergic asthma and rhinitis are characterized by a T-helper type 2 (Th2) response. Treatment of allergic airway diseases is currently limited to drugs that relieve disease symptoms and inflammation. In the search for new therapeutics, efforts have been made to treat allergic airway disease with gene therapy, and many preclinical studies have demonstrated its impressive ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Allergy and Clinical Immunology
سال: 2021
ISSN: 0091-6749
DOI: 10.1016/j.jaci.2021.01.008